Peptide Libraray

Sequence 3 from Patent US 20070293424

General Information

DCTPep ID DCTPep01296

Peptide Name Sequence 3 from Patent US 20070293424

Sequence GGGGWGQGGTHG

Sequence Length 12

UniProt ID B5SY89 P40242 Q6EH52 Q5UJG7 Q5UJG3 P40243

PubChem CID Not available

Origin Tragelaphus strepsiceros

Type Native peptide

Classification

ACP

Activity Information

Hemolytic Activity Not available

Normal (non-cancerous) Cytotoxicity Not available

Target Not available

Affinity Not available

Mechanism Not available

Structure Information

PDB ID Not available

Predicted Structure Not available

(Please note that there is the predicted structure, predicted by AlphaFold)

Helicity Not available

Linear/Cyclic Not available

Disulfide/Other Bond Not available

N-terminal Modification Not available

C-terminal Modification Not available

Other Modification None

Chiral L

Physicochemical Information

Formula C42H58N16O15

Absent amino acids ACDEFIKLMNPRSVY

Theoretical pI 6.74

Acidic residues 0

Basic residues 1

Polar residues 9

Molecular weight (Average) 1027.02

Molecular weight (Monoisotopic) 1026.43

Common amino acids G

Net charge 1

Instability index (II) 36.23

Aliphatic index 0.00

Grand average of hydropathicity (GRAVY) -0.958

Half Life
30 hours (mammalian reticulocytes, in vitro).
>20 hours (yeast, in vivo).
>10 hours (Escherichia coli, in vivo).

Extinction coefficients
Ext. coefficient 5500
Abs 0.1% (=1 g/l) 5.355

Amino acid distribution

Literature Information

Literature 1

Pubmed ID Not available

Title Not available

Doi Not available

Year Not available

Patent

Patent ID US 2007/0293424 A1

Patent Title Antitumoral and Antiviral Peptides.

Other Iinformation Granted Patent Family: 10s / 10ex; Family Jurisdictions: EP, RU, AU, ZA, US, WO; Legal Status: Active; Application No: 58571504 ; Filed:Dec 30, 2004; Published: Dec 20, 2007; Earliest Priority: Jan 15, 2004; Granted: Feb 12, 2013

Other Published ID EP1705182A1 EP1705182A4 EP1705182B1 US8372406 WO2005068491A1